Neuropace, Inc. NPCE Deferred Tax Liabilities
Deferred Tax Liabilities at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxLiabilities.
The official record: Neuropace, Inc.’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s deferred tax liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s deferred tax liabilities?
- Neuropace, Inc. (NPCE) reported deferred tax liabilities of $2.66M in Q4 2025.
- How has Neuropace, Inc.'s deferred tax liabilities changed year-over-year?
- Neuropace, Inc.'s deferred tax liabilities decreased by 11.7% year-over-year, from $3.01M to $2.66M.
- What does deferred tax liabilities mean?
- Future tax obligations from temporary differences — most commonly accelerated tax depreciation that creates higher current tax deductions than book depreciation.